This study aims to systematically elucidate the molecular mechanisms by which CD9 regulates malignant phenotypes and radiosensitivity through the AKT/GSK3β signaling pathway in ESCC. The gene discussed is GSK3B; the disease is esophageal squamous cell carcinoma.